TennCare, Tennessee's Medicaid program, seeks a $975 million budget boost driven in large part by rising costs from drugs ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Eli Lilly and Co. (LLY) has released detailed findings from the Phase 3 SUMMIT trial, demonstrating that tirzepatide significantly ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around ...

By Dr. Sushama R. Chaphalkar, PhD. A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes ...